Breast Neoplasm

Breast neoplasm is a growth in the breast that is abnormal in nature. Neoplasms are not necessarily malignant, but diagnostic tests are usually needed to learn more about the nature of the growth and to develop an appropriate treatment plan.

Showing 1–12 of 23 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
06/2018
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
09/2018
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
09/2018
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
12/2018
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
03/2019
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
08/2019
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
10/2019
185,40 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
03/2021
185,40 
view product
Max: 6
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
09/2017
233,10 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
03/2018
233,10 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
12.5 mg
-80°C
06/2024
443,00 
view product
Max: 10
Min: 1
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
07/2024
206,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Herzuma®
21 mg/mL
6 mg
tba
tba
356,00 
view product
Max:
Min: 7
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ontruzant®
21 mg/mL
2 mg
tba
tba
159,00 
view product
Max:
Min: 15
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Kanjinti®
21 mg/mL
6 mg
-80°C
01/2025
356,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Zercepac®
21 mg/mL
6 mg
-80°C
08/2026
356,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Ogivri®
21 mg/mL
6 mg
-80°C
10/2025
356,00 
view product
Max: 10
Min: 1
Step: 1
HER2
Biosimilar
,
Monoclonal Antibody
Trazimera®
21 mg/mL
2 mg
-80 °C
09/2026
159,00 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
08/2020
147,60 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
02/2021
147,60 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
08/2021
147,60 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
12/2020
147,60 
view product
Max: 10
Min: 2
Step: 1
HER2
Monoclonal Antibody
Herceptin®
21 mg/mL
2 mg
-80°C
03/2023
147,60 
view product
Max: 10
Min: 2
Step: 1

Not looking for Breast Neoplasm?

Search our therapeutic molecules product database